Quest Diagnostics Incorporated
DGX
$230.45-0.94%
End of day · as of Oct 14, 2026, 2:00 AM ET
Mkt cap
$19.94B
EV/Sales
2.24
P/E ratio
24.5
FY2025 Revenue
$11.04B
EPS (TTM)
$9.42
Gross Margin (FY2025)
33.21%
Profit Margin (FY2025)
8.99%
Beta
0.49
Div yield
1.81%
Sector
Healthcare
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported DGX revenue for 2025-12-31 was $11.04B. Net income was $992.0M. Revenue was up 11.8% from 2024-12-31 to 2025-12-31. DGX currently screens at market cap $19.94B and trailing P/E 24.5.
Use this DGX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DGX income, balance, and cash tables.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company in the Healthcare sector.
Latest cached Quest Diagnostics Incorporated (DGX) revenue for Dec 31, 2025 was $11.04B. Net income was $992.0M. Statements: https://lician.com/financials/dgx
Quest Diagnostics Incorporated (DGX) trailing P/E is 24.5 on the latest cached fundamentals snapshot.
Quest Diagnostics Incorporated (DGX) market capitalization is $19.94B on the latest cached snapshot.
Quest Diagnostics Incorporated (DGX) cached previous close $232.63; day range $230.45 – $233.13; volume 1,010,031. Session quote: https://lician.com/quote/dgx
Quest Diagnostics Incorporated (DGX) latest cached earnings event is "DGX earnings" on Jul 23, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DGX filing is 8-K · Oct 6, 2026. Filings: https://lician.com/sec/dgx